BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22222635)

  • 1. Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma.
    Chung YT; Matkowskyj KA; Li H; Bai H; Zhang W; Tsao MS; Liao J; Yang GY
    Mod Pathol; 2012 May; 25(5):758-66. PubMed ID: 22222635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown or inhibition of aldo-keto reductase 1B10 inhibits pancreatic carcinoma growth via modulating Kras-E-cadherin pathway.
    Zhang W; Li H; Yang Y; Liao J; Yang GY
    Cancer Lett; 2014 Dec; 355(2):273-80. PubMed ID: 25304374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulindac inhibits pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice via suppressing aldo-keto reductase family 1B10 (AKR1B10).
    Li H; Yang AL; Chung YT; Zhang W; Liao J; Yang GY
    Carcinogenesis; 2013 Sep; 34(9):2090-8. PubMed ID: 23689354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions.
    Matkowskyj KA; Bai H; Liao J; Zhang W; Li H; Rao S; Omary R; Yang GY
    Hum Pathol; 2014 Apr; 45(4):834-43. PubMed ID: 24656094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention.
    Yan R; Zu X; Ma J; Liu Z; Adeyanju M; Cao D
    Int J Cancer; 2007 Nov; 121(10):2301-6. PubMed ID: 17597105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls.
    Wang C; Yan R; Luo D; Watabe K; Liao DF; Cao D
    J Biol Chem; 2009 Sep; 284(39):26742-8. PubMed ID: 19643728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanism.
    Matsunaga T; Suzuki A; Kezuka C; Okumura N; Iguchi K; Inoue I; Soda M; Endo S; El-Kabbani O; Hara A; Ikari A
    Chem Biol Interact; 2016 Aug; 256():142-53. PubMed ID: 27417252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of AKR1B10 in nasopharyngeal carcinoma as a potential biomarker.
    He YC; Shen Y; Cao Y; Tang FQ; Tian DF; Huang CF; Tao H; Zhou FL; Zhang B; Song L; He L; Lin LM; Lu FG; Liao DF; Cao D
    Cancer Biomark; 2016; 16(1):127-35. PubMed ID: 26835713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of aldo-keto reductase 1B10 is an independent predictor of favorable prognosis in patients with hepatocellular carcinoma.
    Ha SY; Song DH; Lee JJ; Lee HW; Cho SY; Park CK
    Gut Liver; 2014 Nov; 8(6):648-54. PubMed ID: 25287169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
    Torres-Mena JE; Salazar-Villegas KN; Sánchez-Rodríguez R; López-Gabiño B; Del Pozo-Yauner L; Arellanes-Robledo J; Villa-Treviño S; Gutiérrez-Nava MA; Pérez-Carreón JI
    Dig Dis Sci; 2018 Apr; 63(4):934-944. PubMed ID: 29383608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells.
    Ma J; Yan R; Zu X; Cheng JM; Rao K; Liao DF; Cao D
    J Biol Chem; 2008 Feb; 283(6):3418-3423. PubMed ID: 18056116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas.
    Fukumoto S; Yamauchi N; Moriguchi H; Hippo Y; Watanabe A; Shibahara J; Taniguchi H; Ishikawa S; Ito H; Yamamoto S; Iwanari H; Hironaka M; Ishikawa Y; Niki T; Sohara Y; Kodama T; Nishimura M; Fukayama M; Dosaka-Akita H; Aburatani H
    Clin Cancer Res; 2005 Mar; 11(5):1776-85. PubMed ID: 15755999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldo-keto Reductase 1B10 Restrains Cell Migration, Invasion, and Adhesion of Gastric Cancer via Regulating Integrin Subunit Alpha 5.
    Yao H; Hu J; Shao Y; Shah Q; Zheng S
    Turk J Gastroenterol; 2023 Dec; 34(12):1197-1205. PubMed ID: 37823316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldo-keto reductase 1B10 protects human colon cells from DNA damage induced by electrophilic carbonyl compounds.
    Zu X; Yan R; Pan J; Zhong L; Cao Y; Ma J; Cai C; Huang D; Liu J; Chung FL; Liao DF; Cao D
    Mol Carcinog; 2017 Jan; 56(1):118-129. PubMed ID: 26969882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells.
    Liu Z; Yan R; Al-Salman A; Shen Y; Bu Y; Ma J; Luo DX; Huang C; Jiang Y; Wilber A; Mo YY; Huang MC; Zhao Y; Cao D
    Biochem J; 2012 Mar; 442(2):273-82. PubMed ID: 22329800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein 90-α mediates aldo-keto reductase 1B10 (AKR1B10) protein secretion through secretory lysosomes.
    Luo D; Bu Y; Ma J; Rajput S; He Y; Cai G; Liao DF; Cao D
    J Biol Chem; 2013 Dec; 288(51):36733-40. PubMed ID: 24217247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AKR1B10 expression by immunohistochemistry in surgical resections and fine needle aspiration cytology material in patients with cystic pancreatic lesions; potential for improved nonoperative diagnosis.
    Connor JP; Esbona K; Matkowskyj KA
    Hum Pathol; 2017 Dec; 70():77-83. PubMed ID: 29079172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and promoter characterization of aldo-keto reductase family 1 B10 gene.
    Liu Z; Zhong L; Krishack PA; Robbins S; Cao JX; Zhao Y; Chung S; Cao D
    Gene; 2009 May; 437(1-2):39-44. PubMed ID: 19236911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquisition of doxorubicin resistance facilitates migrating and invasive potentials of gastric cancer MKN45 cells through up-regulating aldo-keto reductase 1B10.
    Morikawa Y; Kezuka C; Endo S; Ikari A; Soda M; Yamamura K; Toyooka N; El-Kabbani O; Hara A; Matsunaga T
    Chem Biol Interact; 2015 Mar; 230():30-9. PubMed ID: 25686905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting proliferation and migration of lung cancer using small interfering RNA targeting on Aldo-keto reductase family 1 member B10.
    Zhou Z; Zhao Y; Gu L; Niu X; Lu S
    Mol Med Rep; 2018 Feb; 17(2):2153-2160. PubMed ID: 29207124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.